Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
ACHC 
Acadia Healthcare Company Inc (ACHC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: ACHC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
14 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $42.86
1 Year Target Price $42.86
| 9 | Strong Buy |
| 1 | Buy |
| 4 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -23.54% | Avg. Invested days 38 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.02B USD | Price to earnings Ratio 10.74 | 1Y Target Price 42.86 |
Price to earnings Ratio 10.74 | 1Y Target Price 42.86 | ||
Volume (30-day avg) 14 | Beta 0.94 | 52 Weeks Range 20.36 - 82.41 | Updated Date 06/29/2025 |
52 Weeks Range 20.36 - 82.41 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.04 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 5.94% | Operating Margin (TTM) 10.19% |
Management Effectiveness
Return on Assets (TTM) 5.06% | Return on Equity (TTM) 6.34% |
Valuation
Trailing PE 10.74 | Forward PE 8.3 | Enterprise Value 4253540758 | Price to Sales(TTM) 0.64 |
Enterprise Value 4253540758 | Price to Sales(TTM) 0.64 | ||
Enterprise Value to Revenue 1.35 | Enterprise Value to EBITDA 7.95 | Shares Outstanding 92122200 | Shares Floating 90396715 |
Shares Outstanding 92122200 | Shares Floating 90396715 | ||
Percent Insiders 1.76 | Percent Institutions 109.93 |
Analyst Ratings
Rating 4 | Target Price 42.86 | Buy 1 | Strong Buy 9 |
Buy 1 | Strong Buy 9 | ||
Hold 4 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Acadia Healthcare Company Inc
Company Overview
History and Background
Acadia Healthcare was founded in 2005. It grew rapidly through acquisitions, becoming a leading provider of behavioral healthcare services in the US.
Core Business Areas
- Inpatient Psychiatric Facilities: Operates inpatient psychiatric facilities providing acute care for mental health conditions.
- Residential Treatment Centers: Offers residential treatment programs for substance abuse and behavioral disorders.
- Outpatient Services: Provides outpatient mental health and substance abuse services, including therapy and counseling.
Leadership and Structure
The company is led by CEO Christopher Hunter. It has a board of directors and a structured management team overseeing various operational and administrative functions.
Top Products and Market Share
Key Offerings
- Inpatient Psychiatric Care: Acute care for mental health conditions. Market data is difficult to isolate, but Acadia is a major player in this fragmented market. Competitors include Universal Health Services (UHS) and HCA Healthcare (HCA).
- Substance Use Disorder Treatment: Residential and outpatient programs for substance abuse. Market share data not readily available. Competitors include American Addiction Centers and private rehab facilities.
Market Dynamics
Industry Overview
The behavioral healthcare industry is experiencing growth due to increasing awareness of mental health issues, rising substance abuse rates, and expanding insurance coverage.
Positioning
Acadia Healthcare is a leading provider, with a large network of facilities and a focus on quality care. Their competitive advantage lies in their scale and expertise.
Total Addressable Market (TAM)
The TAM for behavioral health is estimated to be over $100 billion. Acadia's positioning allows them to capture a significant portion of this market, focusing on specific treatment areas and geographic locations.
Upturn SWOT Analysis
Strengths
- Large network of facilities
- Strong reputation for quality care
- Experienced management team
- Diversified service offerings
- Strategic acquisitions for growth
Weaknesses
- High debt levels
- Regulatory scrutiny
- Labor shortages
- Sensitivity to reimbursement changes
Opportunities
- Expanding access to mental health services
- Growing demand for substance abuse treatment
- Telehealth expansion
- Strategic partnerships with healthcare providers
Threats
- Changes in healthcare regulations
- Increased competition
- Economic downturn
- Rising operating costs
Competitors and Market Share
Key Competitors
- UHS
- LHCG
- ACHC
Competitive Landscape
Acadia benefits from its scale, but faces competition from other large providers and smaller, specialized centers. UHS and LHCG compete directly with Acadia.
Major Acquisitions
CenterPointe Behavioral Health System
- Year: 2018
- Acquisition Price (USD millions): 215
- Strategic Rationale: Expanded Acadia's presence in the Midwest and added to its network of behavioral health facilities.
Growth Trajectory and Initiatives
Historical Growth: Acadia has grown through acquisitions and organic expansion of its facilities.
Future Projections: Consult analyst reports for projections.
Recent Initiatives: Focus on expanding telehealth services and optimizing facility operations.
Summary
Acadia Healthcare is a significant player in the behavioral healthcare industry, benefiting from a large network and growing demand. The company faces challenges related to debt and regulatory scrutiny. Strategic acquisitions and a focus on telehealth offer opportunities for continued growth, although competitive pressures and economic factors pose potential threats.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings, investor presentations, industry reports, financial news websites
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market share figures are estimates and may vary. Financial data and analysis are based on available information and are subject to change. Consult with a financial professional before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Acadia Healthcare Company Inc
Exchange NASDAQ | Headquaters Franklin, TN, United States | ||
IPO Launch date 1994-03-04 | CEO & Director Mr. Christopher Howal Hunter | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 25500 | Website https://www.acadiahealthcare.com |
Full time employees 25500 | Website https://www.acadiahealthcare.com | ||
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.